Top Story

FDA approves clinical trial for potential HCC chemotherapy drug

October 30, 2014

The FDA approved the initiation of an investigational device exemption clinical trial of a potential chemotherapy drug, Oncozene, for the treatment of hepatocellular carcinoma, according to a news release from CeloNova BioSciences.

“Our oncozene microspheres platform, when combined with its precise drug delivery capability, presents a potentially improved treatment option for liver cancer patients,” Jane Ren, PhD, chief technology officer at CeloNova, said in the release.  “We are very pleased to be working with the leading [hepatocellular carcinoma] experts in the world to alleviate the pain of our patients.”

figure In the Journals

Thoracic surgeons release new guidelines for treatment of esophageal cancer

October 30, 2014
New evidence-based clinical practice recommendations released by The Society of Thoracic Surgeons outline the importance of multimodality treatment for patients with…
Meeting News Coverage

Small bowel cancer incidence doubled in the UK

October 29, 2014
PHILADELPHIA — The incidence rate of small bowel cancer in the United Kingdom doubled during the past 2 decades, with little improvement in mortality rates…
In the Journals

Mutations in patients with MEN1 increased risk for malignancy, death

October 29, 2014
Patients with multiple endocrine neoplasia type 1 who have mutations leading to a loss of interaction with certain domain codons may be at higher risk for malignancy and…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »

Filter By:

FDA News

FDA approves clinical trial for potential HCC chemotherapy drug

October 30, 2014
The FDA approved the initiation of an investigational device exemption clinical trial of a potential chemotherapy drug, Oncozene, for the treatment…
figure In the Journals

Thoracic surgeons release new guidelines for treatment of esophageal cancer

October 30, 2014
New evidence-based clinical practice recommendations released by The Society of Thoracic Surgeons outline the importance of multimodality treatment…
Meeting News Coverage

Small bowel cancer incidence doubled in the UK

October 29, 2014
PHILADELPHIA — The incidence rate of small bowel cancer in the United Kingdom doubled during the past 2 decades, with little improvement in…
In the Journals

Mutations in patients with MEN1 increased risk for malignancy, death

October 29, 2014
Patients with multiple endocrine neoplasia type 1 who have mutations leading to a loss of interaction with certain domain codons may be at higher…
In the Journals

Patients with colorectal cancer report high financial burden

October 29, 2014
Most respondents to a newly developed patient-reported measure of personal financial burden associated with stage III colorectal cancer reported…
In the Journals

FOLFIRI may be viable first-line regimen for advanced gastric, esophagogastric junction adenocarcinoma

October 29, 2014
Patients with advanced gastric and esophagogastric junction adenocarcinoma who underwent first-line treatment with fluorouracil, leucovorin and…

Shorter colonoscopy withdrawal times increased interval cancer risk

October 28, 2014
PHILADELPHIA — Shorter withdrawal times during screening colonoscopies were associated with increased risk for interval colorectal cancer, and…
figure In the Journals Perspective

Branched-chain amino acids linked to future pancreatic cancer diagnosis

October 28, 2014
Adults who had elevated plasma levels of branched-chain amino acids were at greater than twice the risk for pancreatic cancer, according to study…
figure In the Journals

Novel mutation detected in nearly 20% of colorectal, endometrial cancers

October 26, 2014
Somatic mutations of RNF43 were detected in nearly one of every five colorectal cancers and endometrial cancers, a finding that suggests the novel…
figure Meeting News Coverage

ACG president addresses improved prevention, detection, treatment in IBD cancers

October 24, 2014
PHILADELPHIA — At the ACG Annual Scientific Meeting, the incoming president of the college covered cancer in the setting of ulcerative colitis…
More Headlines »